Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across cancer, cardiovascular disease and inflammation

          Learn more

        • Cancer
        • Inflammation
        • Cardiovascular
        • Programs
        • Laboratories
        • Diseases
        • Expertises
        • Services and instrumentation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in Memory
  • Impact
        • Impact

          Our research develops new diagnostics, treatments and cures for some of the most deadly and debilitating diseases affecting society today

          Learn more

        • Breakthroughs
        • Community and research
  • Careers & studies
        • Careers & Studies

          Take the next step in your career with Centenary, Australia’s foremost clinically integrated medical research institute

          Learn more

        • Career opportunities
        • Life at Centenary
        • Post-Doctorate Research
        • PhD
        • Masters
        • Honours
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
        • Contact
  • Donate
    Centenary Institute > News > The Centenary Institute is excited to join the Sydney Biomedical Accelerator (SBA) as primary medical research partner

The Centenary Institute is excited to join the Sydney Biomedical Accelerator (SBA) as primary medical research partner

Date time 17 June, 2022
News Type News type Media release
The Centenary Institute welcomes the NSW Government’s commitment to fund a new biomedical complex in Camperdown. The Chair of the Centenary Institute Board, Joseph Carrozzi AM, and its Executive Director, Professor Mathew Vadas AO, are thrilled that a biomedical complex, the Sydney Biomedical Accelerator (SBA), will now be a reality.

The SBA will be a state-of-the-art biomedical research complex complementing the University of Sydney and the Royal Prince Alfred Hospital campuses, offering a unique global concentration of biomedical research talent. The Centenary Institute will be the SBA’s primary medical research partner in what will be an exciting and internationally significant precinct.

“The almost 300 staff at the Centenary Institute have been working hard to support the case for this investment by the NSW Government, an investment that will simultaneously accelerate not only finding cures for diseases, but also the commercialisation of our discoveries, the expansion of job opportunities in this thriving sector and promotion of a healthy future for us all,” said Professor Vadas.

“Sydney will now have increased international recognition as a smart and innovative city, a new drawcard for talent, investment and economic activity,” said Mr Carrozzi.

“Having a new hub for medical research and translation in the CBD will allow Sydney to join the great innovative cities which are transforming from business headquarters into active centres for technology, science and discovery, with new and high value jobs in the heart of the city,” added Carrozzi.

Today’s announcement is a continuation of the NSW Government’s commitment to transforming the economy with new high value jobs in science, technology and medical research. The SBA will be a keystone of the recently established Tech Central precinct that will deliver a vibrant innovation and technology community in the heart of Sydney.

“We can’t build a modern, resilient city without core precincts for innovation and high value jobs. The war for talent relies on a compelling story to attract youth, families and entrepreneurs. Our compelling story in Sydney has been led by its unmatched natural beauty, its culture and business centres. Now we will add a new chapter which focuses on discovery, science and smart jobs. Tech Central and the SBA will define Sydney and the entire state as a modern and dynamic place to live, work and play,” Carrozzi said.

“Successful innovation hubs require collaboration between major anchor institutions. In the SBA, we have the Royal Prince Alfred Hospital, an iconic centre for clinical care and research which celebrates 140 years in Sydney, along with the University of Sydney, the oldest university in Australia, and the Centenary Institute, a leading medical research institute which is clinically integrated with RPA and has longstanding and strong research ties with its neighbouring universities,” added Carrozzi.

Acknowledging the role of the Hon. Stuart Ayres, New South Wales Minister for Enterprise, Investment and Trade, in the drive for exciting new technology and science jobs of the future, Carrozzi concluded, “Initiatives such as the SBA will attract the very best talent from around the world, accelerate high-value job growth and development, and enable innovative discoveries that will change not only how we live our lives, but will improve immeasurably, how those lives are actually lived.”

Professor Vadas noted that the SBA will super charge science and research at a time when the world has come to see firsthand the lifesaving work of medical researchers. “The SBA provides clear inter-connection between places for eminent research, partners that enable translation, commercialisation and job-creation and tertiary referrable hospitals and tertiary education centres in healthcare and medicine.”

The commitment to the SBA will now also encourage private sector biomedical businesses to join the precinct to help further accelerate the discovery and translation process. 

People

  • Mr Joseph Carrozzi AM (Chair)

  • Professor Mathew Vadas AO FAHMS

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw, Media and Communications Manager

Phone number Phone Number 0402 770 403

Email Email t.crawshaw@centenary.org.au

Media Release

The Centenary Institute is excited to join the Sydney Biomedical Accelerator (SBA) as primary medical research partner

Download

Recent Stories

  • Centenary researcher wins prestigious cardiac prize

    Centenary Institute researcher and PhD candidate, Dr Julia Isbister, has been awarded the 2022 Ralph Reader Prize for Clinical Science by the Cardiac Society of Australia and New Zealand (CSANZ).
    News Type: Research News
    Date 16 Aug 2022
  • Award for outstanding COVID-19 research paper

    A group of Australian researchers, including Professor Phil Hansbro, Director of the Centenary UTS Centre for Inflammation, have won a Fukuchi (Respirology) Award for ‘outstanding original research paper’ published in the journal Respirology.
    News Type: Research News
    Date 08 Aug 2022
  • DPP9 enzyme role in cancer revealed

    A new study from German and Centenary Institute researchers has provided new understanding of an enzyme called dipeptidyl peptidase 9 (DPP9) and its role in cancer development.
    News Type: Research News
    Date 04 Aug 2022
  • Professor Rasko features in the Sydney Morning Herald

    Professor John Rasko AO, Head of the Gene and Stem Cell Therapy Program at the Centenary Institute has featured in a Sydney Morning Herald (SMH) article on gene therapy and its growing emergence into the clinic.
    News Type: Media coverage
    Date 02 Aug 2022

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Programs
  • Laboratories
  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram